Correlation Between Eyenovia and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eyenovia and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and Allovir, you can compare the effects of market volatilities on Eyenovia and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and Allovir.

Diversification Opportunities for Eyenovia and Allovir

0.89
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Eyenovia and Allovir is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Eyenovia i.e., Eyenovia and Allovir go up and down completely randomly.

Pair Corralation between Eyenovia and Allovir

Given the investment horizon of 90 days Eyenovia is expected to under-perform the Allovir. In addition to that, Eyenovia is 1.94 times more volatile than Allovir. It trades about -0.13 of its total potential returns per unit of risk. Allovir is currently generating about -0.09 per unit of volatility. If you would invest  1,753  in Allovir on October 23, 2024 and sell it today you would lose (825.00) from holding Allovir or give up 47.06% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Eyenovia  vs.  Allovir

 Performance 
       Timeline  
Eyenovia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eyenovia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Allovir 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Allovir has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Eyenovia and Allovir Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eyenovia and Allovir

The main advantage of trading using opposite Eyenovia and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
The idea behind Eyenovia and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios